Global Kyphosis Market Size, Share, Forecast Report, 2020-2027

Kyphosis is a spinal disorder in which an excessive outward curve of the spine results in a weak spine, causing abnormal rounding of the upper back. Kyphosis does not have any characteristic symptom other than a curved/hunched back. However, in certain cases, the disease is reported to cause back pain, tenderness in the spine, and tiredness. If the disease remains unchecked, it can cause severe pain (untreatable by medication) and breathing difficulties. Thus, right and timely diagnosis is crucial.

Osteoporosis (porous bone) is amongst the major causes of kyphosis. The prevalence of osteoporosis is increasing. It has been reported that approximately 10 million people in the Americas suffer from kyphosis. Such a high prevalence of the disease is estimated to increase the kyphosis patient pool, thus increasing the number of patients seeking treatment. Moreover, factors such as the prevalence of kyphosis, rising healthcare expenditure, and increasing R&D in the market by key players is estimated to drive the market growth. In recent years, the prevalence of kyphosis in the Americas was estimated to be about 4% in the general population.

However, factors such as the lack of awareness and limited availability of treatment options restrain market growth.

Conclusively, Kyphosis Market is expected to grow at a healthy CAGR of 5.8% during the forecast period.

Segmentation

The Global Kyphosis Market has been segmented into type, diagnostic test &treatment, and end user.

The market, on the basis of type, has been segmented into postural kyphosis, Scheuermann's kyphosis, and congenital kyphosis.

The market, by diagnostic test & treatment, has been segmented into diagnostic test and treatment. The diagnostic test segment has been segmented into imaging, biopsy, and others. The imaging segment has been divided into X-ray, MRI scan, and CT scan. The treatment segment has been segmented into medications, surgery, and bracing. The medication section has been further sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), and others. The nonsteroidal anti-inflammatory drugs (NSAIDs) has been sub-segmented into aspirin, ibuprofen, and naproxen. The surgery segment is sub-segmented into spinal fusion and osteotomy.

The market, by end-user, has been segmented into hospitals & clinics, diagnostic centers, and academic & research organizations.
Key Players

Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, B. Braun Melsungen AG, Integra LifeSciences, Integra Lifesciences Holdings Corp, Johnson and Johnson (DePuy Synthes), Medtronic Plc., MicroPort Scientific Corporation, Nuvasive Inc., NuVasive, Inc., Orthofix Holdings, Inc., Perrigo Company, Stryker Corporation, Teva Pharmaceuticals USA, Inc., Zimmer Biomet Holdings. Inc., and others are some of the Key Players in the Global Kyphosis Market.

Global Kyphosis Market, by Type

• Postural kyphosis
• Scheuermann's kyphosis
• Congenital kyphosis

Global Kyphosis Market, by Diagnostic Test & Diseases

• Diagnostic Test
  • Imaging
    • X-ray
    • MRI Scan
    • CT Scan
    • Others
  • Biopsy
  • Others
• Treatment
  • Medications
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
    • Aspirin
    • Ibuprofen
    • Naproxen
    • Others
  • Surgery
    • Spinal Fusion
    • Osteotomy
  • Bracing

Global Kyphosis Market, by End User

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Organizations